Top section
Top section
Despite rough market conditions and angst over rates, array of deals have been well taken
It is difficult to see issuance conditions growing much better in the foreseeable future
Trade follows a private placement the bank made after the US-Iran war started
Data
More articles
More articles
More articles
-
Armenia is in the market for its first sovereign Eurobond in four years, hitting screens with a 10 year $500m no-grow. -
Site visits for loan deals are often a bit of a bore. Unless the site was a brewery or distillery where we could sample the product, myself and my peers usually sent minions on the tour instead.
-
HSBC, Macquarie hire former Deutsche bankers – Citi’s Aus, NZ equities head steps down – CIMB rejigs top line-up – Hang Seng’s head of syndication leaves – Moody’s names Apac boss
-
China National Chemical Corp (ChemChina) is seeking lenders’ consent to amend terms of a $5.5bn dual-tranche loan sealed last year, as it undergoes a debt restructuring, according to bankers.
-
Shanghai Henlius Biotech has settled its Hong Kong SAR listing at the bottom of the price guidance, mopping up HK$3.21bn ($410m) from the first post-earnings season IPO in the city.
-
Budweiser Brewing Company Apac has revived its Hong Kong IPO two months after a headline-grabbing flop. But a smaller target size, a stamp of approval from a high-profile cornerstone investor and the off-loading of an unattractive chunk of its business all mean that the firm has a better chance of success this time around. Jonathan Breen reports.
Sub-sections
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
-
-
Sponsored by European Investment Bank
European Investment Bank: Supporting sustainable development in North Africa
